Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
CRISPR company Intellia prices IPO

Gene editing company Intellia Therapeutics Inc. (NASDAQ:NTLA) raised $108 million on Thursday through the sale of 6 million shares at $18 in an IP…

POPULAR TAGS

$41 Million raised for a biotech start-up by founders without biotech background

Written by LVS on in the category news with the tags , .


The San Francisco-based biotech start-up Synthego was founded by 2 engineers who previously worked at SpaceX, the private rocket company founded by Elon Musk. They won support from investors and Dr Jennifer Doudna, one of the leading researchers in the ‘CRISPR-revolution’. Other investors include Yahoo co-founder Jerry Yang and 8VC investors.

The new financing round is meant to help Synthego expand its suite of products, focusing on helping scientists in their CRISPR research by providing important genetic material used in the process.
“Our goal is simple: let’s make it as easy to do biotech research as it is to program a computer,” one of the founders explains to the NYTimes. Investors are impressed: “Synthego will be providing the biotech industry with innovative solutions that make world-class research tools accessible to all scientists” confirms 8VC investors.

More at www.synthego.com and www.nytimes.com

Read more about: , .

RELATED ARTICLES
CRISPR company Intellia prices IPO

Gene editing company Intellia Therapeutics Inc. (NASDAQ:NTLA) raised $108 million on Thursday through the sale of 6 million shares at $18 in an IP…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK Turnstone UGent Flanders.bio Itera Life Science KU Leuven Janssen XpandInnovation V-Bio Ventures Biowin

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.